Hypofractionated vs. single-session Gamma Knife radiosurgery for orbital cavernous hemangiomas: A systematic review, meta-analysis, and institutional case series

IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY
Victor Goulenko , Sarthak Sinha , Venkatesh Shankar Madhugiri , Neil D. Almeida , Robert J. Plunkett , Kenneth V. Snyder , Dheerendra Prasad
{"title":"Hypofractionated vs. single-session Gamma Knife radiosurgery for orbital cavernous hemangiomas: A systematic review, meta-analysis, and institutional case series","authors":"Victor Goulenko ,&nbsp;Sarthak Sinha ,&nbsp;Venkatesh Shankar Madhugiri ,&nbsp;Neil D. Almeida ,&nbsp;Robert J. Plunkett ,&nbsp;Kenneth V. Snyder ,&nbsp;Dheerendra Prasad","doi":"10.1016/j.jocn.2025.111587","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Orbital cavernous hemangiomas (OCH) are rare benign vascular tumors that pose therapeutic challenges due to their proximity to critical visual structures. While surgical resection remains the standard of care, Gamma Knife radiosurgery (GKRS) has emerged as a minimally invasive alternative. However, the optimal fractionation strategy, single-session versus hypofractionated treatment, remains unclear. This review aims to evaluate the clinical and radiological outcomes of single-session versus hypofractionated GKRS for OCH through a systematic review, <em>meta</em>-analysis, and a complementary institutional case series.</div></div><div><h3>Methods</h3><div>A systematic review was conducted following PRISMA guidelines and registered with PROSPERO (registration code:1061256). Databases were searched from inception through April 2025. Eligible studies reported outcomes of GKRS for OCH using either single-session or hypofractionated treatment. Meta-analyses were performed to compare (1) the proportion of patients with tumor volume reduction, (2) the mean percentage reduction in tumor volume, and (3) the proportion of patients with improvement in visual symptoms. Risk of bias was assessed using the Joanna Briggs Institute (JBI) critical appraisal checklists. Funnel plots and Egger’s test were used to assess publication bias. Additionally, three institutional cases treated with GKRS were included to supplement the clinical context.</div></div><div><h3>Results</h3><div>Eleven studies comprising 117 patients were included, with an additional 3 patients from our institution. Tumor volume reduction was observed in 100 % of patients in the fractionated group and 89 % in the single-session group (p = 0.0853). The pooled mean percentage volume reduction was −2.65 % (95 % CI: −6.36 to 3.97) in the fractionated group and −2.85 % (95 % CI: −8.97 to 4.43) in the single-session group (p = 0.9572). Improvement in visual symptoms was seen in 80 % of patients in the fractionated group and 69 % in the single-session group (p = 0.4763). Funnel plots demonstrated minimal publication bias, except for a potential small-study effect in visual symptom outcomes. JBI assessment indicated moderate to high methodological quality across most studies.</div></div><div><h3>Conclusion</h3><div>Both single-session and hypofractionated GKRS appear to be effective and safe treatment options for OCH, with comparable clinical outcomes. Hypofractionation may offer advantages in select patients with optic nerve proximity, though current evidence does not show statistically significant differences between approaches. Single-session GKRS remains a pragmatic and effective option in anatomically favorable cases and may be complemented by adaptive or rescue fractionation strategies when tumor response is suboptimal or recurrence is observed. Prospective multicenter studies with standardized outcome reporting are needed to define optimal treatment strategies.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"141 ","pages":"Article 111587"},"PeriodicalIF":1.8000,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0967586825005600","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Orbital cavernous hemangiomas (OCH) are rare benign vascular tumors that pose therapeutic challenges due to their proximity to critical visual structures. While surgical resection remains the standard of care, Gamma Knife radiosurgery (GKRS) has emerged as a minimally invasive alternative. However, the optimal fractionation strategy, single-session versus hypofractionated treatment, remains unclear. This review aims to evaluate the clinical and radiological outcomes of single-session versus hypofractionated GKRS for OCH through a systematic review, meta-analysis, and a complementary institutional case series.

Methods

A systematic review was conducted following PRISMA guidelines and registered with PROSPERO (registration code:1061256). Databases were searched from inception through April 2025. Eligible studies reported outcomes of GKRS for OCH using either single-session or hypofractionated treatment. Meta-analyses were performed to compare (1) the proportion of patients with tumor volume reduction, (2) the mean percentage reduction in tumor volume, and (3) the proportion of patients with improvement in visual symptoms. Risk of bias was assessed using the Joanna Briggs Institute (JBI) critical appraisal checklists. Funnel plots and Egger’s test were used to assess publication bias. Additionally, three institutional cases treated with GKRS were included to supplement the clinical context.

Results

Eleven studies comprising 117 patients were included, with an additional 3 patients from our institution. Tumor volume reduction was observed in 100 % of patients in the fractionated group and 89 % in the single-session group (p = 0.0853). The pooled mean percentage volume reduction was −2.65 % (95 % CI: −6.36 to 3.97) in the fractionated group and −2.85 % (95 % CI: −8.97 to 4.43) in the single-session group (p = 0.9572). Improvement in visual symptoms was seen in 80 % of patients in the fractionated group and 69 % in the single-session group (p = 0.4763). Funnel plots demonstrated minimal publication bias, except for a potential small-study effect in visual symptom outcomes. JBI assessment indicated moderate to high methodological quality across most studies.

Conclusion

Both single-session and hypofractionated GKRS appear to be effective and safe treatment options for OCH, with comparable clinical outcomes. Hypofractionation may offer advantages in select patients with optic nerve proximity, though current evidence does not show statistically significant differences between approaches. Single-session GKRS remains a pragmatic and effective option in anatomically favorable cases and may be complemented by adaptive or rescue fractionation strategies when tumor response is suboptimal or recurrence is observed. Prospective multicenter studies with standardized outcome reporting are needed to define optimal treatment strategies.
眶海绵状血管瘤的低分割与单次伽玛刀放射治疗:系统回顾、meta分析和机构病例系列
眶海绵状血管瘤(OCH)是一种罕见的良性血管肿瘤,由于其靠近关键的视觉结构,给治疗带来了挑战。虽然手术切除仍然是标准的护理,伽玛刀放射手术(GKRS)已成为一种微创替代方案。然而,最佳分割策略,单疗程还是低分割治疗,仍不清楚。本综述旨在通过系统综述、荟萃分析和补充的机构病例系列,评估单疗程与低分割GKRS治疗OCH的临床和放射学结果。方法按照PRISMA指南进行系统评价,并在PROSPERO注册(注册代码:1061256)。数据库从成立到2025年4月进行了搜索。符合条件的研究报告了GKRS治疗OCH的结果,采用单次治疗或低分割治疗。采用meta分析比较(1)肿瘤体积缩小的患者比例,(2)肿瘤体积缩小的平均百分比,(3)视觉症状改善的患者比例。使用乔安娜布里格斯研究所(JBI)关键评估清单评估偏倚风险。采用漏斗图和Egger检验评估发表偏倚。此外,还纳入了3例接受GKRS治疗的机构病例,以补充临床背景。结果纳入17项研究,共117例患者,另有3例患者来自我院。分次治疗组100%的患者肿瘤体积缩小,单次治疗组89%的患者肿瘤体积缩小(p = 0.0853)。分疗程组的合并平均体积减少百分比为- 2.65% (95% CI: - 6.36至3.97),单疗程组为- 2.85% (95% CI: - 8.97至4.43)(p = 0.9572)。分次治疗组有80%的患者视力症状改善,而单次治疗组有69%的患者视力症状改善(p = 0.4763)。漏斗图显示了最小的发表偏倚,除了视觉症状结果的潜在小研究效应。JBI评估表明,大多数研究的方法学质量中等至较高。结论单次和分位GKRS似乎是治疗OCH的有效和安全的选择,具有相当的临床结果。虽然目前的证据并没有显示不同术式之间有统计学上的显著差异,但在视神经接近的患者中,低分割术可能有优势。在解剖有利的病例中,单期GKRS仍然是一种实用和有效的选择,当肿瘤反应不佳或观察到复发时,可以辅以适应性或救助性分割策略。需要有标准化结果报告的前瞻性多中心研究来确定最佳治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Neuroscience
Journal of Clinical Neuroscience 医学-临床神经学
CiteScore
4.50
自引率
0.00%
发文量
402
审稿时长
40 days
期刊介绍: This International journal, Journal of Clinical Neuroscience, publishes articles on clinical neurosurgery and neurology and the related neurosciences such as neuro-pathology, neuro-radiology, neuro-ophthalmology and neuro-physiology. The journal has a broad International perspective, and emphasises the advances occurring in Asia, the Pacific Rim region, Europe and North America. The Journal acts as a focus for publication of major clinical and laboratory research, as well as publishing solicited manuscripts on specific subjects from experts, case reports and other information of interest to clinicians working in the clinical neurosciences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信